About this episode

The episode explores the intersection of artificial intelligence and neuroscience in understanding and treating neurodegenerative diseases.

Neuroscience and artificial intelligence were once distant disciplines that have been brought together in technological advancement and access to high-quality data. At Dementia Research Oxford, these worlds are coming together to accelerate discoveries in Alzheimer’s and Parkinson’s disease. In the final episode of Season 2 of Balancing the Future , Micah and Chai speak with Dr. Alejo Nevado-Holgado, Associate Professor of Psychiatry at the University of Oxford and Head of the Computational and Molecular Neuroscience Laboratory at Dementia Research Oxford. Together, they explore how advances in computing power and artificial neural networks are transforming our ability to understand, and may eventually help treat, neurodegenerative diseases. The conversation dives into how Dementia Research Oxford bridges wet-lab biology and computational modeling, integrating robotics, genomics, and artificial intelligence to find new drug targets and decode the complexities of the human brain. With access to massive datasets like the UK Biobank, his team can uncover hidden biological patterns and test potential therapies faster than ever before. Neural networks are now being used to predict how…

Explore listener stats, chart rankings, contacts and more on the Balancing The Future podcast page.